Cargando…
Moderate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: study protocol of a placebo controlled, randomised, double blind trial
BACKGROUND: Delirium is a frequent, costly and morbid problem. No agent has been shown to modify the natural history of the condition, and current treatments have significant side effects. Prophylactic melatonin in low doses has been shown to prevent delirium developing. This trial then aims to dete...
Autores principales: | Clayton-Chubb, Daniel I., Lange, Peter W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772311/ https://www.ncbi.nlm.nih.gov/pubmed/26928392 http://dx.doi.org/10.1186/s12877-016-0230-5 |
Ejemplares similares
-
The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial
por: de Jonghe, Annemarieke, et al.
Publicado: (2011) -
Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: A double-blind randomised placebo controlled trial
por: Vijayakumar, HN, et al.
Publicado: (2016) -
The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial
por: Neerland, Bjørn Erik, et al.
Publicado: (2015) -
Effects of Melatonin on Glycemic Variability in Type 2 Diabetes Mellitus: Protocol for a Crossover, Double-Blind, Placebo-Controlled Trial
por: Martorina, Wagner, et al.
Publicado: (2023) -
Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocol
por: Foster, Jennifer, et al.
Publicado: (2016)